Clinical Trial Update: SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating re-treatment with rituximab (MabThera) in rheumatoid arthritis patients who failed anti-TNF therapy has completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-09-15